Pharma Business Week articles from June 2003

Pharma Business Week archives from June 2003

Keppra international Phase IV SKATE study shows favorable efficacy.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- First interim results from UCB Pharma's ongoing Phase IV SKATE (Safety of Keppra as Adjunctive Therapy in Epilepsy) study shows favorable rates of efficacy for Keppra (levetiracetam) in a broad...

FDA approves Velcade treatment.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has announced the approval of Velcade (bortezomib) injection, a new treatment for multiple myeloma. FDA reviewed the application for this drug in less...

New drug discovery tool released.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- ChemAxon, a software solutions provider for biotechnology, announced the release of JChem 2.0, the latest version of the Java database engine enabling chemical communication across networks. The...

Study looks at electronically integrated physician.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- In any given medical practice, in any given exam room, a growing number of patients are dealing with a new type of physician - the electronically integrated physician, dubbed the Essential Integrator....

A year of revaluation and restructuring for biotech.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Against the backdrop of global economic uncertainty, a pending war with Iraq and a bear market, the U.S. biotech industry underwent massive revaluation and restructuring to survive in 2002, according to...

Rothberg Institute using internet to mount computer-based effort against SARS.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- The Rothberg Institute for Childhood Diseases, a nonprofit research institute devoted to discovering and developing drugs for orphan childhood diseases, announced the addition of a recently discovered...

Spectrum announces FDA acceptance of ANDA filing for ciprofloxacin.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc., (SPPI) announced that the U.S. Food and Drug Administration (FDA) has accepted for filing its abbreviated new drug application (ANDA) for ciprofloxacin. The filing...

Alliance focuses on psychiatric disorders.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Argenta Discovery, Ltd., announced that it has entered into a comprehensive, multiyear collaboration with Corcept Therapeutics for the discovery and optimization of a second-generation drug candidate...

Regulatory issues, divestiture analysis detailed in report.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Medical Strategic Planning, Inc., (MSP) has announced immediate availability of its new MSP-2312 report, "Regulatory Issues and Divestiture Opportunities." This new report provides updated...

Drug discovery company reports loss of $0.40 per share.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Caliper Technologies Corp. (CALP) announced its first quarter 2003 financial results. For the quarter ended March 31, 2003, the company reported a net loss of $10.0 million, or $0.40 per share, as...

Loan agreement; restructuring releases $40M of working capital.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Guilford Pharmaceuticals, Inc., (GLFD) announced it has entered into an $18.8 million term loan with Wachovia Bank to restructure the synthetic lease on the company's research and development facility...

Oncology drug maker reports strong results for first quarter 2003.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- GPC Biotech AG (GPC) reported on its successful course of business for the first quarter of 2003. For the 3 months ended March 31, 2003, revenues increased 20.5% to EUR 6.1 million, compared to EUR...

Pharmaceutical company to list on NYSE.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Bradley Pharmaceuticals, Inc., (BPRX) announced its listing on the NYSE from the Nasdaq Stock Exchange, effective May 13, 2003. The company's shares will be traded on the NYSE under the new symbol...

RxStrategies raises $7.8 million in venture financing.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- RxStrategies, Inc., a pharmaceutical services company that serves community health centers (CHCs), announced that it has raised $7.8 million from the sale of series A preferred stock in its first round...

Watson expands alliance with Cipla, Ltd.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Watson Pharmaceuticals, Inc., (WPI) a specialty pharmaceutical company, announced the expansion of its generic product development alliance with Cipla, Ltd. Under the terms of the expanded...

Omnicare and Diabetex partner in federal disease management project.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Omnicare, Inc., (OCR), a provider of pharmaceutical care for the elderly, and Diabetex Corp., a provider of health support and management services for diabetic patients and their physicians, have...

Companies announces antiviral strategic alliance and equity transaction.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Idenix Pharmaceuticals, Inc., announced that Novartis Pharma, AG, an affiliate of Novartis, AG, (NVS), completed the purchase of 51% of the capital stock of Idenix on a fully diluted basis. The...

25 Capital Connection companies receive funding.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Twenty-five (49%) of the 51 emerging technology and biotech companies that were selected to present at the Mid-Atlantic Venture Association's (MAVA) Capital Connection 2002 venture fair have reported...

Building pharma blockbusters requires huge marketing expenditures.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Successful blockbuster pharmaceutical commercialization demands resource support that quickly climbs into the hundreds of millions of dollars, according to a study by pharmaceutical research firm...

Role as life-sustaining technology drives demand for new antibiotics.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Critical care antibiotics play a vital integral role as one of the life-sustaining technologies and bring the patient to a stable condition for better management. With the increase in strains...

New pharma industry guidelines decrease physician access by 25%.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Newly enacted Health Insurance Portability and Accountability Act (HIPAA) guidelines and the 2002 PhRMA code have dramatically cut physician access time for pharmaceutical reps - in some cases by an...

Neurogenetics licenses a phase II AMPA/Kainate receptor.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Neurogenetics, Inc., a privately held biopharmaceutical company, announced an agreement to license and further develop a compound from Eli Lilly and Co. The compound has a unique mechanism of action...

Zahed Subhan named CEO.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Nuevolution, A/S, a privately held drug discovery company, announced the appointment of Zahed Subhan, PhD, MBA, LLB to the position of CEO. Zahed Subhan joins Nuevolution from Locus Pharmaceuticals,...

Kaplan named senior VP, chief financial officer at pharmaceutical firm.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Genaissance Pharmaceuticals, Inc., (GNSC) announced that it has appointed Ben D. Kaplan to the position of senior VP and chief financial officer (CFO). "Ben is an accomplished financial executive...

Arizona Board of Pharmacy urges BBB to warn consumers.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- The Arizona Board of Pharmacy (BOP) issued a letter to the Arizona Better Business Bureau asking it to warn consumers about the risks of purchasing prescription drugs illegally from Canada and other...

Drug testing company announces first quarter results and dividend.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Psychemedics Corp. (PMD) announced first quarter results for the period ending March 31, 2003. The company also announced a quarterly dividend of $.08 per share, which will be paid on June 26,...

Company announces first quarter 2003 financial results.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Rigel Pharmaceuticals, Inc., (RIGL) reported financial results for the first quarter ended March 31, 2003. Rigel reported revenue from collaborations of $4.5 million in the first quarter of 2003,...

More convenient form of Risperdal now available.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- A new, fast-dissolving form of the schizophrenia medication Risperdal (risperidone) has been launched. Risperdal M-TAB dissolves in seconds when placed on the tongue. Risperdal, marketed by Janssen...

Pharma pipeline includes more biotech; future looks bright for innovation.
June 2, 2003... 2003 JUN 2 - (NewsRx.com & NewsRx.net) -- Pharma companies must incorporate more biotech products into their product pipelines, according to a pharmaceutical intelligence report from Cutting Edge Information. Smart deal management, better...

FDA approves Gleevec for pediatric leukemia treatment.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- The U.S. Food and Drug Administration (FDA) has announced the approval of Gleevec (imatinib mesylate) tablets for the treatment of pediatric patients with Philadelphia chromosome positive (Ph+) chronic...

Effect of varying optimization parameters on tablet coating optimum studied.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- AstraZeneca pharmacologists have "investigated the effect of varying optimization parameters on the proposed optimum of a tablet coating formulation requiring minimization of crack velocity and...

Initial accrual in Humax-CD4 phase IIb study complete.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Genmab, A/S, announced that it has completed accrual in its phase IIb clinical study with HuMax-CD4 for the treatment of psoriasis. More than 100 patients with moderate to severe psoriasis are...

Total heart-cut LC-LC-MS technique described for analysis of drug compounds.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Scientists with Monsanto Searle have developed a total heart-cut multidimensional liquid chromatography (LC)/mass spectrometry (MS) technique for the analysis of pharmaceutical compounds. They...

Market awaits newer transdermal drug delivery technologies.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- The launch of newer technology products with a wide range of applications and the ability to deliver proteins, peptides, and large molecules is expected to rake in market revenues. The active...

E-detailing yields increasing ROI in pharmaceutical sales.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Forty-three percent of scheduled rep visits get canceled and 87% of doctor-rep conversations last less than 2 minutes, according to recent research. E-detailing and other new technologies enable...

Strattera will face low reimbursement from HMOs.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Decision Resources finds that Eli Lilly's Strattera will face low or nonexistent reimbursement from HMO pharmacy directors for the treatment of Attention- Deficit/Hyperactivity Disorder (ADHD). ...

Company provides guidance on timing of MBI 226 phase III results.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Micrologix Biotech, Inc., (MGIXF) issued its quarterly CEO message in which Dr. Jim DeMesa, president and CEO, provided comments on various company activities, including an update on the timing of...

New group to focus on cancer diagnostics.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Panacea Pharmaceuticals, Inc., announced the formation of a wholly owned subsidiary, Proteus Diagnostics, Inc., which will focus on developing and commercializing in vitro diagnostics, including...

MetaWorks, Inc., enters marketing partnership.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- MetaWorks, Inc., announced a marketing partnership agreement with Clinquest, Inc. The agreement allows MetaWorks and Clinquest to cross-sell and promote each company's complementary capabilities...

Report says big pharma must evolve.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- A new report published by Decision Resources, Inc., a research and advisory firms focusing on pharmaceutical and health care issues, says that if large pharmaceutical companies want to survive, they...

Penwest reports first quarter financial results.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Penwest Pharmaceuticals Co. (NASDAQ:PPCO) has announced financial results for the first quarter ended March 31, 2003, the first period to report its drug delivery business on a stand-alone basis...

Pharmaceutical company announces net loss of $0.18 per share.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- DOV Pharmaceutical, Inc., (DOVP) announced results for the first quarter ending March 31, 2003. For the first quarter of 2003 the company reported a net loss of $2.6 million, or $0.18 per share,...

Pharmaceutical company reports loss per share of $0.26.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Alliance Pharmaceutical Corp. (ALLP) reported a net loss of $5.1 million, or $0.26 per share, for its third fiscal quarter ended March 31, 2003, compared to a net loss of $6.2 million, or $0.36 per...

Pharmaceutical firm reports $0.18 per share net loss.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Access Pharmaceuticals, Inc., (AKC) reported results for the first quarter ended March 31, 2003. The company reported a net loss of $2,411,000 or $0.18 per share, for the first quarter, as compared...

FDA acceptance of ciprofloxacin ANDA filing triggers strategic investment.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) announced that the U.S. Food and Drug Administration (FDA) acceptance of the Abbreviated New Drug Application (ANDA) for ciprofloxacin by the company's NeoJB...

Arizona seniors to enroll in the state's prescription drug discount program.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- RxAmerica has announced that they are enrolling members in the Arizona Prescription Drug Discount Program for seniors and disabled residents covered by Medicare. Beginning June 1, program...

Biotech fund clarifies identity.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Biotechnology Value Fund, L.P., headquartered in San Francisco, California, stated that neither Biotechnology Value Fund, L.P., nor any of its affiliated entities are related to, or associated with,...

Company prices $175 million of contingent convertible subordinated notes.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- KV Pharmaceutical Co. (KVa/KVb) announced the pricing of $175 million of its contingent convertible subordinated notes due 2033, which are convertible into shares of KV Pharmaceutical Co. Class A common...

Six lawsuits dismissed.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Purdue Pharma L.P., the distributor of Oxycontina (oxycodone HCl controlled-release) Tablets, announced that six lawsuits against the company have been dismissed. The lawsuits claimed that...

E-health executive's cash compensation climbs in 2002.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- While most publicly traded e-health companies continued to show big net losses in 2002, that didn't prevent many of their top executives from enjoying big cash compensation increases, according to...

Partner of choice status still up for grabs in pharma-biotech alliances.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Pfizer has established itself as the "partner of choice" in pharma-pharma alliances, but that title has yet to be claimed in the pharma-biotech arena. First-moving companies stand to gain a great...

Pharmacist groups oppose illegal importation of prescription drugs.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- The American Pharmacists Association (APhA) joined with 44 other U.S. pharmacist groups and the Canadian Pharmacists Association (CPhA) to endorse a landmark Cross-Border Communique between the...

Biopharmaceutical company announces financial results.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Novuspharma, SpA, (NOV.MI), a biopharmaceutical company focused on cancer, announced financial results for the 3 months ended 31 March 2003 and an update on R&D in the first quarter. Among the...

BIO offers message to congress: keep the care in Medicare.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- If Congress doesn't fix a Centers for Medicare and Medicaid Services' (CMS) reimbursement rule, Medicare beneficiaries with various cancers, heart disease, osteoporosis, and multiple sclerosis may soon...

Cox named head of global pharmaceutical business.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Carrie Cox has been appointed as executive vice president and president, Global Pharmaceutical Business, at Schering-Plough Corporation. Cox's appointment is a major element in the early action...

Manuela Niewel, MD, joins drug development company.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- PharmaNet, an international drug development company, announced the appointment of Manuela Niewel, MD, to its oncology division as medical director, oncology, Europe. Niewel, a medical oncologist,...

Nonexecutives step down.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Shire Pharmaceuticals Group, plc, announced that Dr. Francesco Bellini and Gerard Veilleux, both nonexecutive directors, have stepped down from the board, on the expiry of their appointments. Dr...

North joins board of directors at pharmaceutical firm.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- ARC Pharmaceuticals, Inc., announced the appointment of John North to the company's board of directors. "We are pleased to have North join our board. With over 20 years of senior management...

Report shows pharma companies need structural and marketing changes.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- According to a new report, pharmaceutical companies largely ignore the influence of local "thought leaders" on physician attitude and prescribing behavior, although the pharmaceutical industry continues...

Intraject needle-free technology acquired from U.K. company.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Aradigm Corporation (ARDM), a leader in pulmonary drug delivery, announced that it has acquired selected assets of Weston Medical. Weston's proprietary technology, Intraject, offers a needle-free...

Semi-annual changes to the NASDAQ biotechnology index.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- The NASDAQ Stock Market, Inc., announced the semi-annual changes to the NASDAQ Biotechnology Index (NASDAQ:NBI), which became effective on May 19, 2003. The following issues were added to the...

Hepatitis C drug market to grow to $9 billion in 2012.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the hepatitis C virus (HCV) drug market will grow from $2.5...

Report looks at role of nitric oxide in drug development.
June 9, 2003... 2003 JUN 9 - (NewsRx.com & NewsRx.net) -- Jain PharmaBiotech announced the release of the new report titled "Nitric Oxide: Therapeutics, Markets And Companies." This report describes the latest concepts of the role of nitric oxide (NO) in...

Medical science liaisons need greater research and marketing resources.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Pharmaceutical and biotechnology companies have boosted their investments in thought leader management over the last 5 years. But critical opportunities are still being starved, according to...

Market restructuring creates new energy at pharma companies.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Structural changes in pharmaceutical marketing departments have focused companies more closely on rapid commercialization and competitive advantage in a crowded marketplace, according to executives...

Distributor selected for Xolair.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- CuraScript Pharmacy, Inc., announced that it has contracted with Genentech, Inc., and Novartis Pharmaceuticals Corporation to be a participating pharmacy in the Specialty Pharmacy Distribution Network...

Relations between the drug industry and patient groups should be open.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Relationships between the pharmaceutical industry and patients' organizations must be at arm's length and transparent, and not affect the agenda and priorities of these groups, argues a senior doctor....

Report: Too many firms chasing drug discovery, too few pursuing diagnostics.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- More life-science informatics vendors target drug R&D than the market can support, while few target diagnostic applications that could quickly scale up to the larger point-of-care market. That is...

DNA, protein, tissue, arrays market expected to reach $1.6B by 2008.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- The worldwide arrays market is projected to experience a 15% overall compound annual growth rate (CAGR) over the next 5 years as pharmaceutical and biotechnology companies seek more efficient and cost...

Many Americans think an HIV/AIDS vaccine already exists.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Many Americans wrongly believe that a preventive vaccine for HIV/AIDS has already been developed, according to surveys recently conducted by the National Institute of Allergy and Infectious Diseases...

Aerospan appears to reduce inflammation, improve lung function.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Forest Laboratories, Inc., (FRX) announced the results of a lung biopsy study, which showed that Aerospan (flunisolide hemihydrate HFA) Inhalation Aerosol significantly reduced both large and small...

Measurement of metabolic rate called a breakthrough for bariatric physicians.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Korr Medical Technologies recently presented the REEVUE Indirect Calorimeter at the American Society of Bariatric Physicians (ASBP) in Las Vegas, Nevada. The REEVUE brings metabolic measurements to...

Kendle CEO addresses European pharmaceutical outsourcing community.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Kendle International, Inc., (KNDL) Chairman and CEO Candace Kendle, PharmD, addressed more than 200 senior-level pharmaceutical and biotechnology executives at the 2003 European "Partnerships in...

NIH awards grant to develop test for biowarfare agents.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Genomic Profiling Systems, Inc., announced that it has received a phase I small business innovation research grant (SBIR) from the U.S. National Institutes of Health (NIH) for $119,820 to develop its...

Private/public partnership bring affordable care to Hong Kong.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- AmMed Cancer Center, Hong Kong Adventist Hospital, and a number of cancer drug manufacturers have jointly developed cancer diagnostic and treatment packages to benefit patients currently under...

U.S. patent issued for new formulations of anticancer drug.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- SuperGen, Inc., (NASDAQ:SUPG) announced that it has been issued U.S. Patent No. 6,538,020, which covers new and improved formulations of the anticancer drug paclitaxel, methods of manufacturing these...

Oncolytics announces issuance of seventh U.S. patent.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Oncolytics Biotech, Inc., (ONCY) announced that it has been granted U.S. patent 6,565,831 entitled "Method of Preventing Reovirus Recognition for the Treatment of Cellular Proliferative Disorders." ...

Endothelin A antagonist SPP301 Development and Commercialization Rights Acquired.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- The Speedel Group, a Swiss pharmaceutical company focused on cardiovascular and metabolic drug development, announced that it has exercised its option to license from Roche all rights to SPP301, which...

Drug manufacturer sees continuing positive momentum for 2003.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Dan K. Wassong, chairman, president, and CEO of Del Laboratories, Inc., (DLI) spoke at the company's Annual Meeting about the company's outstanding performance in 2002, and discussed the company's...

Data: Drug wholesalers lead e-marketing pack.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- According to the U.S. Census Bureau's newly published "2001 E-Stats Report," e-commerce sales by wholesalers grew at a healthy clip of 13% while their overall sales were relatively flat between...

Health Alliance Program cuts risk of polypharmacy.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Americans are at increased risk of polypharmacy - the overuse, underuse, and misuse of medications. Michigan-based Health Alliance Plan has teamed pharmacists with physicians in an effort to...

Offer price for pharmaceutical firm increased; mesalamine results presented.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Axcan Pharma, Inc., (AXCA) announced that it is increasing the price of its cash tender offer for all of the outstanding shares of common stock of Salix Pharmaceuticals, Ltd. (SLXP) to U.S. $10.50 per...

Registration statement filed for secondary offering.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- Endo Pharmaceuticals Holdings, Inc., (ENDP) announced that it has filed a registration statement on Form S-3 with the U.S. Securities and Exchange Commission (SEC) in connection with a secondary...

Small molecules company completes $9M equity deal.
June 16, 2003... 2003 JUN 16 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc., (ENMD) announced it has completed the sale of 3.0 million shares of common stock to institutional investors for approximately $9.0 million in gross proceeds. The shares were...